Literature DB >> 21153651

Microscopic lesions of placenta and Doppler velocimetry related to fetal growth restriction.

Natalija Vedmedovska1, Dace Rezeberga, Uldis Teibe, Ivars Melderis, Gilbert G G Donders.   

Abstract

PURPOSE: The purpose of the study was to find an association between the uterine and umbilical arteries blood flow patterns in growth-restricted (FGR) and normal fetuses and placental microscopic lesions.
METHODS: Fifty women with prenatally suspected and post-delivery confirmed FGR of singleton fetuses were enrolled in a case-controlled follow-up study from May 2007 to December 2008. Unselected patients with appropriately growing fetuses, matched for gestational age, served as controls. Uterine and umbilical Doppler waveforms were recorded before delivery.
RESULTS: Compared with control group with normal Doppler, FGR women with abnormal Doppler velocimetry of uterine and umbilical arteries had more intervillous thrombi (p = 0.01 and p < 0.0001, respectively) and villous infarctions (p = 0.02 and p = 0.0003, respectively). Thickening of the basal membrane and villitis was clearly linked to the FGR (p = 0.006 and p = 0.01). Vasculitis, on the other hand, is linked to normal growth, without affecting Doppler velocities.
CONCLUSIONS: Abnormal Doppler may predict hemorrhagic and ischemic placental lesions in FGR pregnancies and may lead to future improvement of the management of current and subsequent pregnancies.

Entities:  

Mesh:

Year:  2010        PMID: 21153651     DOI: 10.1007/s00404-010-1781-x

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  2 in total

Review 1.  Maternal Low Volume Circulation Relates to Normotensive and Preeclamptic Fetal Growth Restriction.

Authors:  Wilfried Gyselaers; Christoph Lees
Journal:  Front Med (Lausanne)       Date:  2022-06-09

2.  Introducing a Mobile-Connected Umbilical Doppler Device (UmbiFlow™) into a Primary Care Maternity Setting: Does This Reduce Unnecessary Referrals to Specialised Care? Results of a Pilot Study in Kraaifontein, South Africa.

Authors:  Josef Mufenda; Stefan Gebhardt; Rita van Rooyen; Gerhard Theron
Journal:  PLoS One       Date:  2015-11-23       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.